viewICC Intl Cannabis Corp.

ICC International Cannabis applauds Wayland's winning of key government certifications for German cultivation facility

The certificates will help to improve production at Wayland's cultivation facility outside of Dresden

map of Germany
The market for medical cannabis in Germany is burgeoning, with over 79,000 German patients now taking the drug

The announcement that Wayland Group (CSE:WAYL) has received key certifications from the German state of Saxony for its Ebersbach cultivation facility is welcome news for ICC International Cannabis Corp (CSE:WRLD.U) (OTCMKTS:KNHBF), which is set to take a large stake in the company.

The country's good manufacturing practice and good distribution practice certifications apply to a 50,000 square foot area of Wayland’s Ebersbach cultivation facility, which is located just outside of Dresden, Germany.

The new certifications will allow for the streamlining of production processes for the cannabis company and also permit the bulk warehousing of medical cannabis on German soil, allowing for direct sale into the German market, according to ICC.

READ: ICC International Cannabis to acquire 49.9% of Wayland assets

The market for medical cannabis in Germany is burgeoning, with more than 79,000 German patients now taking the drug, according to ICC.

Just last month, ICC International Cannabis struck a letter of intent to acquire 49.9% of Wayland’s international assets and license portfolio. A definitive agreement sealing the move is expected on or before March 1.

After the deal closes, ICC will have considerable input about the direction of Wayland's German operations.

“International Cannabis applauds the Ebersbach facility’s receipt of the prestigious good manufacturing practice and good distribution practice certifications,” said Eugene Beukman, CEO of International Cannabis, in a statement.

“EU-GMP certifications mark the highest standards of pharmaceutical production in the world. Receipt of EU-GMP certifications by the Ebersbach facility will streamline production processes, resulting in shorter lead times and higher margins,” he added.

READ: ICC International Cannabis and Wayland Group to begin CBD extraction

The Ebersbach facility is equipped with 820,000 square feet of clean-room cultivation space. Production of CBD isolate from the Ebersbach facility amounted to 2,400 kg in 2018.

 The company expects Ebersbach will eventually apply for a German indoor medical THC cultivation license and will control an outdoor CBD cultivation operation as well.

Wayland shares slipped 4.7% to C$1.22 in afternoon trade on Friday while ICC International Cannabis shares held steady at C$0.345.

Contact Ellen Kelleher at ellen@proactiveinvestors.com

Quick facts: ICC Intl Cannabis Corp.

Price: - -

Market: CSE
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ICC Intl Cannabis Corp. named herein, including the promotion by the Company of ICC Intl Cannabis Corp. in any Content on the Site, the Company...


ICC International Cannabis boss says it is helping force the black market...

ICC International Cannabis Corp (CSE:WRLD) (OTCMKTS:KNHBF) CEO David Shpilt joins Christine Corrado in the Proactive Investors New York studio to talk about his thoughts on the decriminalization of cannabis in the Empire State, and how these changing regulations are a signal that the industry...

on 07/30/2019

2 min read